Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global In-Vitro Toxicology Testing Market Trends and Forecast
3.3: Global In-Vitro Toxicology Testing Market by Product and Service
3.3.1: Consumables
3.3.2: Assays
3.3.2.1: Bacterial Toxicity Assays
3.3.2.2: Enzyme Toxicity Assays
3.3.2.3: Cell-based Elisa & Western Blots
3.3.2.4: Receptor-binding Assays
3.3.2.5: Tissue Culture Assays
3.3.2.6: Other Assays
3.3.3: Equipment
3.3.4: Software
3.3.5: Services
3.4: Global In-Vitro Toxicology Testing Market by Method
3.4.1: Cellular Assays
3.4.2: Biochemical Assays
3.4.3: In Silico Models
3.4.4: Ex Vivo Models
3.5: Global In-Vitro Toxicology Testing Market by Toxicity Endpoint & Test
3.5.1: ADME
3.5.2: Skin Irritation, Corrosion, & Sensitization
3.5.3: Genotoxicity Testing
3.5.4: Cytotoxicity Testing
3.5.5: Ocular Toxicity
3.5.6: Organ Toxicity
3.5.7: Phototoxicity Testing
3.5.8: Dermal Toxicity
3.5.9: Other Toxicity Endpoints & Tests
3.6: Global In-Vitro Toxicology Testing Market by End Use Industry
3.6.1: Pharmaceuticals & Biopharmaceuticals
3.6.2: Cosmetic & Household Products
3.6.3: Food
3.6.4: Chemicals
3.7: Global In-Vitro Toxicology Testing Market by Technology
3.7.1: Cell Culture Technologies
3.7.2: High-throughput Technologies
3.7.3: Toxicogenomics
4. Market Trends and Forecast Analysis by Region
4.1: Global In-Vitro Toxicology Testing Market by Region
4.2: North American In-Vitro Toxicology Testing Market
4.2.1: Market by Product & Service: Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, and Other Assays), Equipment, Software, and Services
4.2.2: Market by Method: Cellular Assays, Biochemical Assays, In Silico Models, and Ex Vivo Models
4.2.3: Market by Toxicity Endpoint & Test: ADME, Skin Irritation, Corrosion, & Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, and Other Toxicity Endpoints & Tests
4.2.4: Market by End Use Industry: Pharmaceuticals & Biopharmaceuticals, Cosmetic & Household Products, Food, and Chemicals
4.2.5: Market by Technology: Cell Culture Technologies, High-Throughput Technologies, and Toxicogenomics
4.2.6: The United States In-Vitro Toxicology Testing Market
4.2.7: The Canadian In-Vitro Toxicology Testing Market
4.2.8: The Mexican In-Vitro Toxicology Testing Market
4.3: European In-Vitro Toxicology Testing Market
4.3.1: Market by Product & Service: Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, and Other Assays), Equipment, Software, and Services
4.3.2: Market by Method: Cellular Assays, Biochemical Assays, In Silico Models, and Ex Vivo Models
4.3.3: Market by Toxicity Endpoint & Test: ADME, Skin Irritation, Corrosion, & Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, and Other Toxicity Endpoints & Tests
4.3.4: Market by End Use Industry: Pharmaceuticals & Biopharmaceuticals, Cosmetic & Household Products, Food, and Chemicals
4.3.5: Market by Technology: Cell Culture Technologies, High-Throughput Technologies, and Toxicogenomics
4.3.6: The United Kingdom In-Vitro Toxicology Testing Market
4.3.7: The Spanish In-Vitro Toxicology Testing Market
4.3.8: The German In-Vitro Toxicology Testing Market
4.3.9: The French In-Vitro Toxicology Testing Market
4.4: APAC In-Vitro Toxicology Testing Market
4.4.1: Market by Product & Service: Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, and Other Assays), Equipment, Software, and Services
4.4.2: Market by Method: Cellular Assays, Biochemical Assays, In Silico Models, and Ex Vivo Models
4.4.3: Market by Toxicity Endpoint & Test: ADME, Skin Irritation, Corrosion, & Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, and Other Toxicity Endpoints & Tests
4.4.4: Market by End Use Industry: Pharmaceuticals & Biopharmaceuticals, Cosmetic & Household Products, Food, and Chemicals
4.4.5: Market by Technology: Cell Culture Technologies, High-Throughput Technologies, and Toxicogenomics
4.4.6: The Chinese In-Vitro Toxicology Testing Market
4.4.7: The Indian In-Vitro Toxicology Testing Market
4.4.8: The Japanese In-Vitro Toxicology Testing Market
4.5: ROW In-Vitro Toxicology Testing Market
4.5.1: Market by Product & Service: Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, and Other Assays), Equipment, Software, and Services
4.5.2: Market by Method: Cellular Assays, Biochemical Assays, In Silico Models, and Ex Vivo Models
4.5.3: Market by Toxicity Endpoint & Test: ADME, Skin Irritation, Corrosion, & Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, and Other Toxicity Endpoints & Tests
4.5.4: Market by End Use Industry: Pharmaceuticals & Biopharmaceuticals, Cosmetic & Household Products, Food, and Chemicals
4.5.5: Market by Technology: Cell Culture Technologies, High-Throughput Technologies, and Toxicogenomics
4.5.6: Brazilian In-Vitro Toxicology Testing Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global In-Vitro Toxicology Testing Market by Product and Service
7.1.2: Growth Opportunities for the Global In-Vitro Toxicology Testing Market by Methpd
7.1.3: Growth Opportunities for the Global In-Vitro Toxicology Testing Market by Toxicity Endpoint & Test
7.1.4: Growth Opportunities for the Global In-Vitro Toxicology Testing Market by End Use Industry
7.1.5: Growth Opportunities for the Global In-Vitro Toxicology Testing Market by Technology
7.1.6: Growth Opportunities for the Global In-Vitro Toxicology Testing Market by Region
7.2: Emerging Trends in the Global In-Vitro Toxicology Testing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global In-Vitro Toxicology Testing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global In-Vitro Toxicology Testing Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: Thermo Fisher Scientific
8.2: Covance
8.3: Bio-Rad Laboratories
8.4: GE Healthcare
8.5: Eurofins Scientific
8.6: Merck
8.7: Charles River Laboratories
8.8:Catalent
8.9: Cyprotex
8.10: SGS